Archives of Pharmacal Research

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Application of Microencapsulated Isoflavone into Milk

  • Jeon, Byung-Ju (Department of Food Science and Technology, Sejong University) ;
  • Kim, Nam-Chul (Department of Food Science and Technology, Sejong University) ;
  • Han, Eun-Mi (Department of Food Science and Technology, Sejong University) ;
  • Kwak, Hae-Soo (Department of Food Science and Technology, Sejong University)
  • Published : 2005.07.01
Download PDF
⟨ Previous Next ⟩

Abstract

This study was designed to develop a microencapsulated, water-soluble isoflavone for application into milk and to examine the hypocholesterolemic effect of such a milk product in a rat diet. The coating material was medium-chain triglyceride (MCT) and the core material was watersoluble isoflavone. The microencapsulation efficiency was 70.2% when the ratio (w/w) of coating material to core material was 15:1. The isoflavone release from the microcapsules was 8% after 3-day storage at $4^{\circ}C$. In in vitro study, 4.0-9.3% of water-soluble isoflavone in simulated gastric fluid was released in the pH range of 2 to 5 after 60 min incubation; however, in simulated intestinal fluid at pH 8, 87.6% of isoflavone was released from the capsules after 40 min incubation time. In sensory analysis, the scores of bitterness, astringency, and off-taste in the encapsulated isoflavone-added milk were slightly, but not significantly, different from those in uncapsulated, isoflavone-added milk. In blood analysis, total cholesterol was significantly decreased in the isoflavone-added group compared with that in the control after 6-week feeding. Therefore, this study confirmed the acceptability of MCT as a coating material in the microencapsulation of water-soluble isoflavone for application into milk, although a slight adverse effect was found in terms of sensory attributes. In addition, blood total cholesterol was lowered in rats which had been fed a cholesterol-reduced and microencapsulated, isoflavoneadded milk for 6 weeks.

Keywords

References

  1. Adlercreutz, H., Phytoestrogens: epidemiology and a possible role in cancer protection. Environ. Health Perspect., 103 (suppl. 7), 103-112 (1995) https://doi.org/10.1289/ehp.95103s9103
  2. Ali, A. A., Velasquez, M. T., Hansen, C. T., Mohamed, A. I., and Bhathena, S. J., Effects of soybean isoflavones, probiotics, and their interactions on lipid metabolism and endocrine system in an animal model of obesity and diabetes. J. Nutr. Biochem., 15, 583-590 (2004) https://doi.org/10.1016/j.jnutbio.2004.04.005
  3. Anthony, M. S., Clarkson, T. B., Hughes, C. L., Morgan, T. M., and Burke, G. L., Soybean isoflavones improve cardiovascular risk factor without affecting the reproductive system of peripubertal rhesus monkeys. J. Nutr., 126, 43-50 (1996) https://doi.org/10.1093/jn/126.1.43
  4. Arliss, R. M. and Biermann, C. A., Do soy isoflavones lower cholesterol, inhibit atherosclerosis, and play a role in cancer prevention. Holist. Nutr. Pract., 16(5), 40-48 (2002) https://doi.org/10.1097/00004650-200201000-00007
  5. Barnes, S., Kim, H., and Darley-Usmer. V., Beyond ER$\alpha$ and Er$\beta$: Estrogen receptor binding is only part of the isoflavone story. J. Nutr., 130, 6565-6575 (2000)
  6. Berserieva, E. A., Inanov, A. A., Sansonova, T. P., Chermova, E. M., and Oragvelidze, E. M., Microencapsulated aromatizers for tea. Pishchevaya Promyshlennost. USSR, 1, 57-59 (1990)
  7. Braun, S. D. and Olson, N. F., Encapsulation of proteins and peptides in milk fat. Encapsulation efficiency and temperature and freezing stability. J. Microencapsulation, 3, 115-126 (1986) https://doi.org/10.3109/02652048609031566
  8. Cassidy, A., Bingham, S., and Setchell, K. D. R., Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal woman. Am. J. Clin. Nutr., 60, 333-347 (1994) https://doi.org/10.1093/ajcn/60.3.333
  9. Fanti, P., Monier-Faugere, M. C., Geng, Z., Schmidt, J., Morris (Ed- confirm), P. E., Cohen, D., and Malluche, H. G., The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats. Osteoporos. Int., 8, 274-281 (1998) https://doi.org/10.1007/s001980050065
  10. Food and Drug Administration. Food labeling health claims: soy protein and coronary heart disease. Food and Drug Administration. Final Rule. Fed. Regist., 64, 57700-57733 (1999)
  11. Freund, O. J., Amedee, D. R., and Laversanne, R., In vitro and in vivo stability of new multilamellar vesicles. Life Sci., 67, 411-419 (2000) https://doi.org/10.1016/S0024-3205(00)00640-8
  12. Fukui, K., Tachibana, N., Wanezaki, S., Tsuzaki, S., Takamatsu, K., Yamamoto, T., Hashimoto, Y., and Shimoda, T., Isoflavonefree soy protein prepared by column chromatography reduces plasma cholesterol in rats. J. Agric. Food Chem., 50, 5717-5721 (2002) https://doi.org/10.1021/jf025642f
  13. Grundy, S. M., Brheimer, D., Blackburn, H., Brown, W. V., Kwiterovich, P. O., Mattson, F., Schonfeld, G., and Weidman, W. H., Rationale of the diet-heart statement of the American Heart Association Report of the Nutrition Committee. Circulation, 65, 839A-854A (1982) https://doi.org/10.1161/01.CIR.65.5.839
  14. Gurr, M. I., Dietary lipids and coronary disease: old evidence, new perspectives and progress. Lipid Res., 31, 195-243 (1992) https://doi.org/10.1016/0163-7827(92)90009-8
  15. Jackson, L. S. and Lee, K., Microencapsulated iron for food fortification. J. Food Sci., 56, 1047-1050 (1991) https://doi.org/10.1111/j.1365-2621.1991.tb14638.x
  16. Kwak, H. S., Kwon, S. H., Lee, J. B., and Ahn, J., In vitro stability of $\beta$-galactosidase microcapsules. Asian-Aust. J. Anim. Sci., 15, 1808-1818 (2002) https://doi.org/10.5713/ajas.2002.1808
  17. Kwak, H. S., Ihm, M. R., and Ahn, J., Microencapsulation of $\beta$- galactosidase with fatty acid esters. J. Dairy Sci., 84, 1576- 1582 (2001) https://doi.org/10.3168/jds.S0022-0302(01)74590-0
  18. Kwak, H. S., Yang, K. M., and Ahn, J., Microencapsulated iron for milk fortification. J. Agric. Food Chem., 51, 770-7774 (2003)
  19. Lissin, L. W. and Cooke, J. P., Phytoestrogens and cardiovascular health. J. Am. Coll. Cardiol. 35, 1403-1410 (2000) https://doi.org/10.1016/S0735-1097(00)00590-8
  20. Magee, E. L. Jr. and Olson, N. F., Microencapsulation of cheese ripening systems: Formation of microcapsules. J. Dairy Sci., 64, 600-610 (1981a) https://doi.org/10.3168/jds.S0022-0302(81)82618-5
  21. Magee, E. L. Jr. and Olson, N. F., Microencapsulation of cheese ripening systems : Stability of microcapsules. J. Dairy Sci., 64, 611-615 (1981b) https://doi.org/10.3168/jds.S0022-0302(81)82619-7
  22. SAS User's Guide, Statistics, Version 5 Edition. SAS Inst., Inc., Cary, NC, U.S.A. (1985)
  23. Seok, J. S., Kim, J. S., and Kwak, H. S., Microencapsulation of water-soluble isoflavone and physico-chemical property in milk. Arch. Pharm. Res., 26, 426-431 (2003) https://doi.org/10.1007/BF02976702
  24. Setchell, K. D. R. and Cassidy, A., Dietary isoflavones: Biological effects and relevance to human health. J. Nutr., 129, 758S-767S (1999) https://doi.org/10.1093/jn/129.3.758S
  25. Tikkanen, M. J. and Adlercreutz, H. Dietary soy-derived isoflavone phytoestrogens. Biochem. Pharmacol., 60, 1-5 (2000) https://doi.org/10.1016/S0006-2952(99)00409-8